Citation: N. Nagai et al., Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: A prospective follow-up study, ONCOL REP, 8(1), 2001, pp. 119-125
Authors:
Kume, S
Toharmat, T
Nonaka, K
Oshita, T
Nakui, T
Ternouth, JH
Citation: S. Kume et al., Relationships between crude protein and mineral concentrations in alfalfa and value of alfalfa silage as a mineral source for periparturient cows, ANIM FEED S, 93(3-4), 2001, pp. 157-168
Authors:
Nagai, N
Oshita, T
Fujii, T
Katsube, Y
Matsubayashi, S
Ohama, K
Citation: N. Nagai et al., Are DNA ploidy and epidermal growth factor receptor prognostic factors foruntreated ovarian cancer? A prospective study, AM J CL ONC, 24(3), 2001, pp. 215-221
Authors:
Inoue, K
Mimori, Y
Harada, T
Oshita, T
Kumagai, R
Nakamura, S
Citation: K. Inoue et al., The relationship between photosensitive temporal lobe epilepsy and eye closure activity, SEIZURE-E J, 9(5), 2000, pp. 347-351
Authors:
Nagai, N
Oshita, T
Fujii, T
Kioka, H
Katsube, Y
Ohama, K
Citation: N. Nagai et al., Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer, ONCOL REP, 7(3), 2000, pp. 551-559
Citation: T. Oshita et al., Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer, INT J ONCOL, 17(6), 2000, pp. 1225-1230
Citation: N. Nagai et al., Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions, ONCOL REP, 6(2), 1999, pp. 325-328
Authors:
Oshita, T
Nagai, N
Murakami, J
Sakata, K
Shigemasa, K
Ohama, K
Citation: T. Oshita et al., Expression of human telomerase reverse transcriptase (hTERT) mRNA in endometrial adenocarcinoma, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 121-123
Authors:
Nagai, N
Oshita, T
Murakami, J
Shigemasa, K
Ohama, K
Fujii, T
Katsube, Y
Citation: N. Nagai et al., Clinical evaluation of DNA ploidy and EGFR as a risk factor in gynecologicmalignancies, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 269-271